In breast cancer patients, a more severe phenotype has been reported in individuals with double heterozygosity for disease-causing BRCA1 and BRCA2 mutations, two genes of the Fanconi anemia/Breast cancer pathway [30]. The gene discussed is BRCA2; the disease is breast carcinoma.